- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Biomaterials
Volume 2011 (2011), Article ID 175362, 8 pages
Bacterial Cellulose-Hydroxyapatite Nanocomposites for Bone Regeneration
1Institute of Chemistry, University Estadual Paulista—UNESP, CP 355, 14-801-970 Araraquara, SP, Brazil
2Department of Inorganic Chemistry, Institute of Chemistry—UNESP, Rua Francisco Degni s/n, 14-800-900 Araraquara, SP, Brazil
3Department of Morphology, Dental School, University Estadual Paulista—UNESP, Rua Humaitá, 1680, 14-801-903 Araraquara, SP, Brazil
Received 28 March 2011; Revised 1 June 2011; Accepted 7 July 2011
Academic Editor: Traian V. Chirila
Copyright © 2011 S. Saska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The aim of this study was to develop and to evaluate the biological properties of bacterial cellulose-hydroxyapatite (BC-HA) nanocomposite membranes for bone regeneration. Nanocomposites were prepared from bacterial cellulose membranes sequentially incubated in solutions of CaCl2 followed by Na2HPO4. BC-HA membranes were evaluated in noncritical bone defects in rat tibiae at 1, 4, and 16 weeks. Thermogravimetric analyses showed that the amount of the mineral phase was 40%–50% of the total weight. Spectroscopy, electronic microscopy/energy dispersive X-ray analyses, and X-ray diffraction showed formation of HA crystals on BC nanofibres. Low crystallinity HA crystals presented Ca/P a molar ratio of 1.5 (calcium-deficient HA), similar to physiological bone. Fourier transformed infrared spectroscopy analysis showed bands assigned to phosphate and carbonate ions. In vivo tests showed no inflammatory reaction after 1 week. After 4 weeks, defects were observed to be completely filled in by new bone tissue. The BC-HA membranes were effective for bone regeneration.
Recently, a new generation of resorbable materials has been developed for soft and/or bone tissue regeneration purposes [1–4], including bacterial cellulose (BC), which has shown possible osteoconduction properties [5–10].
BC is obtained from cultures of a Gram-negative bacteria, Gluconacetobacter xylinus, which produces highly hydrated membranes (up to 99% water), free of lignin and hemicelluloses, and which presents a higher molecular weight and crystallinity than plant cellulose. BC membranes show great elasticity, high wet strength, and conformability . The gelatinous membrane formed in static culture is characterized by a 3D structure consisting of an ultrafine network of cellulose nanofibres (“nanocelluloses”), resulting in a large nanoporous surface area. The unique properties provided by the nanometric structure have led to a number of commercial products and medical applications such as wound dressings and skin substitutes . BC membranes present important characteristics such as biocompatibility, bioinertness, biodegradability, and selective permeability. Furthermore, they also play the role of barrier against microorganisms in wounds and burns, accelerating the healing process, providing pain relief and reducing scar formation [13–15]. BC membranes have been used for guided bone regeneration (GBR) in bone defects of critical and noncritical size, in periodontal lesions, and as a resorbable barrier membrane occluding fibroblastic cells and fibrous connective tissue into bone defects. Moreover, the results from the literature have revealed that BC membranes promote effective bone formation at the site, besides being a low-cost treatment [16–19]. Fang et al.  showed that HA/BC nanocomposite scaffolds developed were biocompatible and could promote cell proliferation and differentiation in vitro using stromal cells derived from human bone marrow (hBMSC). Other in vitro studies have revealed that BC-HA composites have a great potential for application in tissue engineering or bone regeneration as well [21, 22]. Therefore, BC-hydroxyapatite (BC-HA) composites should also be good candidates for bone regeneration, because this composite may promote better bone regeneration, mainly for GBR. Basically, two main routes have been proposed for the preparation of composite membranes. The first includes a biomimetic route in which the BC membrane is submitted to pretreatment with a Ca(OH)2 or CaCl2 solution. Afterwards, the membrane is soaked in an SBF solution, where HA formation occurs mainly at the membrane surface [5, 6, 8–10]. The second route includes cyclic treatments with CaCl2 and sodium phosphate solutions .
This paper aims to describe the preparation and characterization of BC-HA composite membranes; in addition, biological behavior of the composite membranes was evaluated in noncritical bone defects in rat tibiae.
2. Materials and Methods
2.1. Preparation of Bacterial Cellulose-Hydroxyapatite Composites (BC-HA)
Bacterial cellulose membranes were supplied from Fibrocel (Produtos Biotecnológicos LTDA, Ibiporã, PR, Brazil).
Incorporation of hydroxyapatite (HA) into the BC hydrogel was performed following the methodology proposed by Hutchens et al. . Highly hydrated BC membranes (2 × 2 cm2, 5 mm thickness) were immersed in 20% ethanol at room temperature (25°C) for 24 h. HA was formed in BC by alternating incubation cycles in 20 mL of 0.05 mol·L−1 CaCl2 solution (pH 5.8) and 20 mL of 0.1 mol·L−1 Na2HPO4 solution (pH 9.1) at 25°C. The samples were dried at 50°C for 7 days and sterilized by gamma radiation (20 kGy).
2.2. Characterization of BC-HA Composites
Thermogravimetric (TG) curves of the dried samples were recorded using a TA SDT 2960 from TA Instruments Co. Samples were heated in open α-alumina pans from 40°C to 600°C under a nitrogen atmosphere (flow rate: 70 mL min−1) at a heating rate of 10°C min−1. X-rays diffraction (XRD) patterns were obtained using a Kristalloflex Simens Diffractometer with a Ni filter and Cu Kα radiation from 4° to 70°. Fourier transform infrared (FT-IR) spectra were obtained from dried powdered samples on a Perkin Elmer Spectrum 2000 Fourier transform infrared spectrophotometer. Pellets were prepared from mixtures of the samples and KBr (1 : 100 in weight). Thirty-two scans were accumulated at a resolution of 4 cm−1. Scanning electron microscopy (SEM) images and energy-dispersive X-ray spectroscopy (EDS) analysis were obtained from an FEG XL 30-Philips. After EDS analysis, samples were coated with a 1 nm thin layer of gold for 60 s (3 kV and 9.5 μA).
2.3. In Vivo Experiment
Eighteen male adult rats (Rattus Norvevicus Holtzman) were used in the study. The Animal Experimentation Ethics Committee of the Pharmaceutical School of Araraquara-UNESP approved all animal experimental protocols. General anesthesia was induced using intramuscular injections of ketamine hydrochloride (0.1 mL/100 g; Agener União, Brazil) and xylazine hydrochloride (0.01 mL/100 g; Bayer, Brazil). Surgery was performed using standard aseptic techniques. An incision of approximately 10 mm was made on the anterior region of each tibia. Tibiae were exposed and one noncritical size bone defect (2 mm in diameter) approximately 1 cm from the distal extremity was created in each tibia based on a previous study . The bone defects were performed with a surgical drill (2 mm in diameter; Neodent, Brazil), under copious saline irrigation, drilling into the full thickness of cortical and exposing the bone marrow. In the treated group, the left tibia defects were filled with a blood clot and recovered by the BC-HA barrier composite membrane (4 mm × 4 mm). In the control group, the right tibia defects were filled with a blood clot only. The flaps were sutured with 4–0 mononylon (Ethicon, Johnson & Johnson, Brazil). In the immediate postoperative period all animals received an oral administration (single dose) of 120–300 mg/kg of salicylic acid (Bayer-Brazil). Six animals were evaluated after 1, 4, and 16 weeks. The specimens were reduced, preserving the periosteum. The samples were fixed in Bouin for 72 hours before further analysis. Decalcification of the samples was performed with a solution containing equal parts of 50% formic acid and 20% sodium citrate. Routine histological processing for light microscopy was carried out, and 6 μm sections were stained with hematoxylin-eosin (H. E.). Sections were analyzed under an optical microscope (Jenaval-Zeiss) coupled to a digital camera (Leica DFC425). The parameters analyzed were examined by a researcher who was blinded to the two treatment groups for mineralized bone quality, cellular activity including osteoblasts, osteoids, and osteocytes as well as any evidence of fibrotic tissue formation within the defect site, angiogenesis processes, inflammatory reactions, and degradation of the membranes. The results of degradation of the BC-HA membranes were analyzed using BioEstast 5.0 statistical software. A two-way ANOVA was carried out to evaluate the measured values (ImageJ software) from membranes for statistical significance among periods 7, 30, and 120 days. Statistical significance was established at .
3. Results and Discussion
3.1. Characterization of BC-HA Nanocomposites
Figure 1 shows the TG results of the BC and BC-HA composite membranes with or without gamma radiation sterilization. Thermogravimetric analysis was carried out to estimate thermal stability and degradation profiles of the BC and BC-HA composites.
At around 320°C–350°C decomposition of the samples led to an important weight loss. These events could be associated with a cellulose degradation process including depolymerization, dehydration, and decomposition of glucosyl units followed by the formation of a charred residue [5, 24, 25].
A carbonaceous residue was observed for the pure BC membrane, around 10% at 600°C. BC-HA composites presented a residue around 60%, confirming HA deposition on the BC membrane, which means that HA content was around 50%.
The onset temperature observed in the TG curves revealed that the thermal stability of BC decreased with the presence of HA. The of BC was at 352°C, and of the composites, BC-HA and sterilized BC-HA, were at 332°C and 333°C, respectively. This behavior may be associated with broken hydrogen bonds and the reduced crystallinity of BC; thus, reduced crystallinity leads to a decrease in values . According to Gao et al. , HA crystals did not show sufficient barrier properties for delaying heat and gas diffusion to BC, because HA nanoparticles did not cover the entire surface of BC nanofibres . Furthermore, gamma radiation did not promote changes in the characteristic temperatures of BC-HA composites. This result permitted us to infer that gamma radiation is an adequate treatment for BC-HA composite sterilization.
Figure 2 shows the X-ray diffraction patterns obtained for the BC membrane and BC-HA composite. Typical BC crystalline phases were observed in both samples. Characteristic peaks of BC-HA crystals were identified as JCPDF 46-0905. Diffraction peaks at 2θ = 15° and 22.5° were assigned to the cellulose Iα and Iβ phases (1001α, 1101β and 0101β planes at 15° and 1101α and 2001β at 22.5°) . The main characteristic diffraction peaks of HA crystal phase were observed at 2θ = 29°, 32°, 40°, and 51° (Figure 2(b)). XRD pattern was in fact very similar to the XRD pattern of bone apatite, suggesting low crystallinity . According to Hutchens et al. , the decrease in the intensity of the cellulose peaks in comparison with the pattern obtained from the pure BC membrane was due to HA deposition on BC nanofibrils. The residue observed in thermogravimetric analysis for temperatures above that of cellulose decomposition averaged 50% and must be related to the HA weight average.
The FT-IR spectra of dried BC membranes and BC-HA composite membranes are shown in Figure 3. Characteristic vibrational frequencies assigned to cellulose were observed at 3500–3200 cm−1 (OH stretching), 2908 cm−1 (CH stretching of CH2 and CH3 groups), 2700 cm−1 (CH2), 1645 cm−1 (water OH bending), 1435 cm−1 (CH2 symmetric bending), 1370 cm−1 (CH bending), 1160 cm−1 (antisymmetric bridge C–O–C stretching), 1111 cm−1, and 1056 cm−1 (skeletal vibrations involving C–O stretching) . The band in the region from 3500–3200 cm−1, assigned to cellulose hydroxyl groups, was observed with decreasing relative intensity for the composite in comparison with the pure BC membrane. This decrease in intensity suggests that the presence of the HA crystals affected the cellulose hydroxyl groups. Moreover the red shift observed for the band assigned to intramolecular hydrogen bonding (~3500 cm−1) confirms strong interaction between the OH group and apatite. The chemical interaction between HA and BC stabilizes the composite so that it can maintain the mechanical integrity necessary for bone substitution. FT-IR bands observed for BC-HA composite at 1093, 1020, 962, and 570–600 cm−1 were attributed to vibrational modes of PO43− ions [5–8]. The 962 cm−1 peak showed up as a shoulder of the stronger band at the 1020 cm−1 peak, and the weak bands at 1418 and 838 cm−1 (inset picture) correspond to the stretching mode of CO32− ions, suggesting absorption of CO2 from the air. The presence of the PO43− doublet band at 602 cm−1 and 567 cm−1 (inset figure) strongly suggest that the precursor phase of the HA was the OCP . Therefore, FT-IR analysis suggested carbonate-containing apatite (bonelike apatite) deposited on BC nanofibres.
SEM images of the BC and BC-HA composites are shown in Figure 4. Figure 4(c) shows a typical SEM image of dried BC membrane. An ultrafine network structure formed by continuous nanofibres about 10–50 nm wide (“nanocelluloses”) can be observed. This nanometric structure leads to a large surface area for particle stabilization . Figures 4(a) and 4(b) show SEM images of the dried BC-HA nanocomposite. HA nanocrystals were precipitated on the BC nanofibrils as agglomerates of crystallites Figure 4(a); regularly distributed pores were observed at the membrane surface. Typical HA crystals in globular and rod form were observed, similar to the HA crystals as has also been observed by other authors [31, 32]. These crystals grew laterally around the nanofibres. According to EDS analysis, the Ca/P molar ratio of the BC-HA composites was 1.50 suggesting calcium-deficient HA (CDHA), which is a phase similar to biological apatite. The low crystallinity was consistent with the broadness of the diffraction peaks of HA shown in Figure 2(b). Moreover, this Ca/P molar ratio favors faster dissolution of the Ca2+ and PO43− ions. Lower Ca/P molar ratio values lead to higher dissolution of Ca2+ ions, with an increase in local pH at the biomaterial/tissue interface, promoting the ideal pH for alkaline phosphatase activity. Therefore, osteoblast proliferation and synthesis of bone matrix may be increased.
Calcium phosphates have different solubility and the comparative extent of dissolution is: OCP (Ca/P = 1.33) ≫ ß-tricalcium phosphate (ß-TCP) (Ca/P = 1.48) > calcium-deficient HA (CDHA) (Ca/P = 1.5) ≫ HA (Ca/P = 1.67). This difference reproduces the influence of composition and crystallographic properties of calcium phosphate, since stoichiometric HA is insoluble in body fluids [33, 34].
3.2. Histological Analysis
Figures 5(a) and 5(b) show images obtained from the control and treated groups after 1 week, respectively. The BC-HA nanocomposite membrane, osteoblasts, osteoids, newly formed bone, and medullary spaces with mesenchymal cells were observed within the defect site. However, in the control group, fibrotic tissue formation was observed within the defect site. Moderate inflammatory reaction could be observed for both groups in this period. At 4 weeks, newly formed bone tissue containing medullary spaces with mesenchymal cells, several osteocytes, and blood vessels were observed for control group; however, the newly formed bone was not integrated with tibia bone as shown in Figure 5(c). Figure 5(d) shows that after 4 weeks, bone defects were observed to be filled by new formed bone with several osteocytes, blood vessels, and bone matrix in process of mineralization; the BC-HA membrane was observed in this period. Inflammatory reaction was not found in these two groups at 4 weeks. After 16 weeks, the BC-HA membrane was observed yet. Bone defects were completely repaired by mature bone for both groups (Figures 5(e) and 5(f)).
BC-HA nanocomposite membranes were biocompatible and did not promote an inflammatory reaction after 4 weeks. Literature shows, in fact, that BC derivatives alone have been employed in soft tissues showing no inflammatory or foreign body reaction [15, 35]. It must be mentioned that HA-plant cellulose derivatives have been employed in rat bone defects showing inflammatory and foreign body reactions. In another experiment, plant cellulose sponges were filled by connective tissue and did not promote complete bone defect ossification .
Promising results have been obtained using BC membranes in intrabony periodontal defects as low-cost resorbable barriers [16, 17]. Clinical results were observed to be similar to those obtained from more expensive e-PTFE barriers in intrabony periodontal defects promoting effective new bone formation . Studies have demonstrated that there was no additional advantage of using associated other alloplastic materials compared with BC membrane alone [18, 19].
In the present study, no membrane exposure was observed. Similar results were observed by dos Anjos et al.  and by Simonpietri et al. . However, Batista et al.  observed membrane exposure using BC membranes in guided bone regeneration at a rate of 15.38% in the first 10 days; however, no abscesses or acute inflammatory reaction could be observed.
Bone defects treated with BC-HA nanocomposite membranes presented defects that were filled by newly formed bone tissue organized and incorporated to the tibia bone in a period of 4 weeks. In the control group, new formed bone tissue was observed to be partially incorporated to the tibia bone in the same period of time. After 16 weeks, no differences could be observed between the groups. Bone defects were completely filled by mature bone for both groups.
There are few studies reported in the literature evaluating the biological properties of BC-HA composites in vitro [20–22]. Moreover, there are no reports in the literature studying BC-HA composites in in vivo studies. However, there are several studies in the literature evaluating the biological properties of BC membranes in in vivo [13–19, 35, 37, 38], whose studies have revealed that BC membranes are a biomaterial in potential for application in tissue regeneration due to their great biological properties. Thus, the results of this study are pioneering in that they showed that BC-HA nanocomposites were compatible with the examined structures, including hard and soft tissues.
The ANOVA showed that there was a significant statistical difference regarding the degradation of BC-HA membranes between 7 and 120 days . In addition, the effect of degradation of the membranes depend on the period analyzed . The mean values of the degradation of the membranes are showed in Table 1. Mello et al.  observed similar results for reabsorption of the BC membranes as substitute for the dura mater in dogs, and decrease in membranes thickness was statistically significant between 30 to 270 days.
Biomaterial reabsorption is related to several factors such as particle size, porosity, chemical structure (composition and crystallinity), and pH of body fluids . Particles with nanometric sizes are reabsorbed faster than micrometric particles, because osteoclasts or macrophages act more readily on a biomaterial surface. Biomaterial crystallinity also changes the reabsorption rate, since highly crystalline structures are more resistant to reabsorption than an amorphous or semicrystalline structure. Moreover, the chemical composition is also important. Impurities such as calcium carbonate promote faster reabsorption. Therefore, the chemical structure of BC-HA nanocomposite membranes, the HA particle, and BC nanofibres sizes suggests favoring reabsorption of this new biomaterial.
BC-HA composites have presented HA nanocrystals of low crystallinity in the membranes with a Ca/P molar rate similar to that of physiological bone. The BC-HA membranes were effective for bone regeneration in bone defects of rat tibiae, since the membranes accelerated new bone formation at the defect sites; in addition, reabsorption of the membranes was slow, suggesting that this composite takes longer to be completely reabsorbed.
Financial support from the Brazilian agencies FAPESP (Project no. 08-58776-6) and CNPq is acknowledged. The authors wish to thank Mr. Luis Antônio Potenza for technical support.
- M. Duskova, E. Leamerova, B. Sosna, and O. Gojis, “Guided tissue regeneration, barrier membranes and reconstruction of the cleft maxillary alveolus,” Journal of Craniofacial Surgery, vol. 17, no. 6, pp. 1153–1160, 2006.
- F. P. Strietzel, P. Khongkhunthian, R. Khattiya, P. Patchanee, and P. A. Reichart, “Healing pattern of bone defects covered by different membrane types-a histologic study in the porcine mandible,” Journal of Biomedical Materials Research—part B, vol. 78, no. 1, pp. 35–46, 2006.
- A. Sculean, F. Schwarz, G. C. Chiantella et al., “Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR,” Journal of Clinical Periodontology, vol. 34, no. 1, pp. 72–77, 2007.
- J. H. Song, H. E. Kim, and H. W. Kim, “Collagen-apatite nanocomposite membranes for guided bone regeneration,” Journal of Biomedical Materials Research—part B, vol. 83, no. 1, pp. 248–257, 2007.
- Y. Z. Wan, Y. Huang, C. D. Yuan et al., “Biomimetic synthesis of hydroxyapatite/bacterial cellulose nanocomposites for biomedical applications,” Materials Science and Engineering C, vol. 27, no. 4, pp. 855–864, 2007.
- P. Cromme, C. Zollfrank, L. Müller, F. A. Müller, and P. Greil, “Biomimetic mineralisation of apatites on activated cellulose templates,” Materials Science and Engineering C, vol. 27, no. 1, pp. 1–7, 2007.
- S. A. Hutchens, R. S. Benson, B. R. Evans, H. M. O'Neill, and C. J. Rawn, “Biomimetic synthesis of calcium-deficient hydroxyapatite in a natural hydrogel,” Biomaterials, vol. 27, no. 26, pp. 4661–4670, 2006.
- L. Hong, Y. L. Wang, S. R. Jia, Y. Huang, C. Gao, and Y. Z. Wan, “Hydroxyapatite/bacterial cellulose composites synthesized via a biomimetic route,” Materials Letters, vol. 60, no. 13-14, pp. 1710–1713, 2006.
- A. Bodin, L. Gustafsson, and P. Gatenholm, “Surface-engineered bacterial cellulose as template for crystallization of calcium phosphate,” Journal of Biomaterials Science, vol. 17, no. 4, pp. 435–447, 2006.
- T. T. Nge and J. Sugiyama, “Surface functional group dependent apatite formation on bacterial cellulose microfibrils network in a simulated body fluid,” Journal of Biomedical Materials Research—part A, vol. 81, no. 1, pp. 124–134, 2007.
- W. Czaja, D. Romanovicz, and R. M. Brown Jr., “Structural investigations of microbial cellulose produced in stationary and agitated culture,” Cellulose, vol. 11, no. 3-4, pp. 403–411, 2004.
- C. Bodhibukkana, T. Srichana, S. Kaewnopparat et al., “Composite membrane of bacterially-derived cellulose and molecularly imprinted polymer for use as a transdermal enantioselective controlled-release system of racemic propranolol,” Journal of Controlled Release, vol. 113, no. 1, pp. 43–56, 2006.
- R. C. Mayall, A. C. Mayall, L. C. Mayall, et al., “Tratamento das úlceras tróficas dos membros com um novo substituto da pele,” Revista Brasileira de Cirurgia, vol. 80, no. 4, pp. 257–283, 1990.
- J. D. Fontana, A. M. de Souza, C. K. Fontana et al., “Acetobacter cellulose pellicle as a temporary skin substitute,” Applied Biochemistry and Biotechnology, vol. 24-25, pp. 253–264, 1990.
- D. Klemm, B. Heublein, H. P. Fink, and A. Bohn, “Cellulose: fascinating biopolymer and sustainable raw material,” Angewandte Chemie, vol. 44, no. 22, pp. 3358–3393, 2005.
- B. dos Anjos, A. B. Novaes, R. Meffert, and E. Porto Barboza, “Clinical comparison of cellulose and expanded polytetrafluoroethylene membranes in the treatment of Class II furcations in mandibular molars with 6-month re-entry,” Journal of Periodontology, vol. 69, no. 4, pp. 454–459, 1998.
- A. B. Novaes Jr., N. H. Moraes, A. B. Novaes, et al., “Uso do BioFill como membrana biológica no tratamento da lesão de furca com e sem a utilização da hidroxiapatita porosa,” Revista Brasileira de Odontologia, vol. 47, no. 5, pp. 29–32, 1990.
- E. L. Batista, A. B. Novaes, J. J. C. Simonpietri, and F. C. Batista, “Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry,” Journal of Periodontology, vol. 70, no. 9, pp. 1000–1007, 1999.
- J. J. Simonpietri-C, A. B. Novaes Jr., E. L. Batista Jr., and E. J. Feres Filho, “Guided tissue regeneration associated with bovine-derived anorganic bone in mandibular class II furcation defects. 6-month results at re-entry,” Journal of Periodontology, vol. 71, no. 6, pp. 904–911, 2000.
- B. Fang, Y. Z. Wan, T. T. Tang, C. Gao, and K. R. Dai, “Proliferation and osteoblastic differentiation of human bone marrow stromal cells on hydroxyapatite/bacterial cellulose nanocomposite scaffolds,” Tissue Engineering—part A, vol. 15, no. 5, pp. 1091–1098, 2009.
- C. J. Grande, F. G. Torres, C. M. Gomez, et al., “Nanocomposites of bacterial cellulose/hydroxyapatite for biomedical applications,” Acta Biomaterialia, vol. 5, no. 5, pp. 1605–1615, 2009.
- K. A. Zimmermann, J. M. LeBlanc, K. T. Sheets, R. W. Fox, and P. Gatenholm, “Biomimetic design of a bacterial cellulose/hydroxyapatite nanocomposite for bone healing applications,” Materials Science and Engineering C, vol. 31, no. 1, pp. 43–49, 2011.
- J. K. Armstrong, B. Han, K. Kuwahara et al., “The effect of three hemostatic agents on early bone healing in an animal model,” BMC Surgery, vol. 10, article 37, pp. 1–12, 2010.
- H. S. Barud, A. M. de Araújo Júnior, D. B. Santos et al., “Thermal behavior of cellulose acetate produced from homogeneous acetylation of bacterial cellulose,” Thermochimica Acta, vol. 471, no. 1-2, pp. 61–69, 2008.
- H. S. Barud, C. A. Ribeiro, M. S. Crespi et al., “Thermal characterization of bacterial cellulose-phosphate composites membranes,” Journal of Thermal Analysis and Calorimetry, vol. 87, no. 3, pp. 815–818, 2007.
- C. Gao, G. Y. Xiong, H. L. Luo, K. J. Ren, Y. Huang, and Y. Z. Wan, “Dynamic interaction between the growing Ca-P minerals and bacterial cellulose nanofibers during early biomineralization process,” Cellulose, vol. 17, no. 2, pp. 365–373, 2010.
- H. S. Barud, R. M. N. Assunção, M. A. U. Martines et al., “Bacterial cellulose-silica organic-inorganic hybrids,” Journal of Sol-Gel Science and Technology, vol. 46, no. 3, pp. 363–367, 2008.
- S. N. Danilchenko, C. Moseke, L. F. Sukhodub, and B. Sulkio-Cleff, “X-ray diffraction studies of bone apatite under acid demineralization,” Crystal Research and Technology, vol. 39, no. 1, pp. 71–77, 2004.
- G. R. Sauer and R. E. Wuthier, “Fourier transformed infrared characterization of mineral phases formed during induction of mineralization by colagenase-released matrix vesicles in vitro,” Journal of Biological Chemistry, vol. 263, no. 27, pp. 13718–13724, 1988.
- H. S. Barud, C. Barrios, T. Regiani et al., “Self-supported silver nanoparticles containing bacterial cellulose membranes,” Materials Science and Engineering C, vol. 28, no. 4, pp. 515–518, 2008.
- L. Morejón-Alonso, R. G. Carrodeguas, and J. A. D. García-Menocal, “Transformations in CDHA/OCP/β-TCP scaffold during ageing in simulated body fluid at ,” Journal of Biomedical Materials Research—part B, vol. 84B, no. 2, pp. 386–393, 2008.
- L. Morejón-Alonso, R. G. Carrodeguas, J. A. D. García-Menocal, J. A. A. Pérez, and S. M. Manent, “Effect of sterilization on the properties of CDHA-OCP-β-TCP biomaterial,” Materials Research, vol. 10, no. 1, pp. 15–20, 2007.
- L. Le Guéhennec, P. Layrolle, G. Daculsi, H. Redl, A. Pandit, and J. Czernuszka, “A review of bioceramics and fibrin sealant,” European Cells and Materials, vol. 8, pp. 1–10, 2004.
- C. E. Misch, Implantes Dentários Contemporâneos, Santos, São Paulo, Brazil, 2nd edition, 2006.
- G. Helenius, H. Bäckdahl, A. Bodin, U. Nannmark, P. Gatenholm, and B. Risberg, “In vivo biocompatibility of bacterial cellulose,” Journal of Biomedical Materials Research—part A, vol. 76, no. 2, pp. 431–438, 2006.
- E. Ekholm, M. Tommila, A. P. Forsback et al., “Hydroxapatite coating of cellulose sponge does not improve its osteogenic potency in rat bone,” Acta Biomaterialia, vol. 1, no. 5, pp. 535–544, 2005.
- L. R. Mello, L. T. Feltrin, P. T. Fontes Neto, and F. A. P. Ferraz, “Duraplasty with biosynthetic cellulose: an experimental study,” Journal of Neurosurgery, vol. 86, no. 1, pp. 143–150, 1997.
- P. N. Mendes, S. C. Rahal, O. C. M. Pereira-Junior et al., “In vivo and in vitro evaluation of an Acetobacter xylinum synthesized microbial cellulose membrane intended for guided tissue repair,” Acta Veterinaria Scandinavica, vol. 51, no. 1, article 12, pp. 1–8, 2009.